Life Sciences: Pharma Regulatory Submission Review with Codex: Sandbox Policy
A production playbook for pharma regulatory submission review in life sciences operations using Codex: sandbox policy, run-scoped inputs, logs, typed results, and artifacts.
Audience: Life sciences regulatory teams
The problem
Life sciences regulatory teams need pharma regulatory submission review to run repeatedly against submission packets, study reports, labeling docs, and regulator comments. In life sciences operations, the pain is not one good answer; it is repeatability, auditability, exception handling, and evidence that survives handoff.
Implementation path
Run pharma regulatory submission review in an ephemeral sandbox, keep provider credentials in the broker, expose narrow tools, and store logs outside the workspace for review.
Tradeoffs and failure modes
A narrower runtime blocks ambient machine behavior, but it gives security reviewers a concrete boundary. For pharma regulatory submission review, the practical test is whether a second run can be debugged, retried, and consumed by a product without reading the raw agent transcript.
Runtime boundary
filesystem: /skill and /skill/.argo/inputs only
network: deny by default
artifacts: /skill/output/artifacts
logs: retained outside sandbox
provider: Codex
Run this on Argo